This article is more than 5 years old. Information may no longer be current.
UK researcher receives award
Click Here to Manage Email Alerts
Jack Cuzick
The American Association for Cancer Research and the Prevent Cancer Foundation presented Jack Cuzick, PhD, with the AACR-Prevent Cancer Foundation Award.
The award recognizes seminal laboratory, translational, clinical, epidemiological or behavioral science contributions to the field of cancer prevention.
“I am delighted to receive this award in recognition of all those who have been a part of my work over the past decades,” Cuzick, head of the Cancer Research U.K. Center for Cancer Prevention, a professor of epidemiology at the Wolfson Institute of Preventative Medicine at Queen Mary University of London and president of the International Society for Cancer Prevention, said in a press release. “This has been an extraordinary period to be in this field, and I have been lucky enough to benefit from working with so many first class researchers from around the world.”
In 1985, Cuzick observed that adjuvant tamoxifen reduced the incidence of second primary breast cancers and proposed its prophylactic use in women at an increased risk. Four large tamoxifen chemoprevention trials have been completed, all of which confirmed Cuzick’s observation.
Cuzick also was a leading proponent of HPV screening, demonstrated the efficacy of endoscopic screening for colorectal cancer and helped to assemble the largest cohort of men with localized prostate cancer who are managed by watchful waiting.